YTS104 Cell Injection for the Treatment of Relapsed or Refractory Multiple Myeloma

NCT05913804 · clinicaltrials.gov ↗
PHASE1
Phase
RECRUITING
Status
12
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Institute of Hematology & Blood Diseases Hospital, China

Collaborators